Genomics & Gene Editing
Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.
199 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $32.7B | +$1.02B | 92 | 1.4% | Increased |
|
| 2 |
BlackRock
New York
| $29.2B | -$636M | 99 | 1.43% | Reduced |
|
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
| $18B | -$171M | 48 | 2.85% | Reduced |
|
| 4 |
Fidelity Investments
Boston,
Massachusetts
| $17.7B | +$1.37B | 62 | 2.45% | Increased |
|
| 5 |
State Street
Boston,
Massachusetts
| $15.8B | +$175M | 77 | 1.38% | Increased |
|
| 6 |
Wellington Management Group
Boston,
Massachusetts
| $10B | -$17.2M | 35 | 2.66% | Reduced |
|
| 7 |
Capital World Investors
Los Angeles,
California
| $9.7B | -$90.4M | 18 | 2.81% | Reduced |
|
| 8 |
Massachusetts Financial Services
Boston,
Massachusetts
| $8.09B | -$391M | 18 | 3.86% | Reduced |
|
| 9 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
| $6.98B | -$16.2M | 12 | 7.56% | Reduced |
|
| 10 |
Capital Research Global Investors
Los Angeles,
California
| $6.87B | -$988M | 10 | 2.7% | Reduced |
|
| 11 |
Morgan Stanley
New York
| $6.67B | -$87.3M | 106 | 1.81% | Reduced |
|
| 12 |
Bank of America
Charlotte,
North Carolina
| $5.87B | +$185M | 98 | 1.06% | Increased |
|
| 13 |
Geode Capital Management
Boston,
Massachusetts
| $5.72B | +$104M | 100 | 1.49% | Increased |
|
| 14 |
Northern Trust
Chicago,
Illinois
| $4.82B | +$11.1M | 88 | 1.38% | Increased |
|
| 15 |
Primecap Management
Pasadena,
California
| $4.74B | -$181M | 13 | 4.65% | Reduced |
|
| 16 |
Norges Bank
Oslo,
Norway
| $4.34B | +$69M | 39 | 1.55% | Increased |
|
| 17 |
Janus Henderson Group
London,
| $4.04B | +$37.7M | 22 | 2.78% | Increased |
|
| 18 |
JP Morgan Chase
New York
| $3.92B | +$263M | 86 | 0.92% | Increased |
|
| 19 |
Bank of New York Mellon
New York
| $3.8B | +$424M | 81 | 1.26% | Increased |
|
| 20 |
Invesco
Atlanta,
Georgia
| $3.36B | +$139M | 51 | 1.42% | Increased |
|
| 21 |
Loomis, Sayles & Company
Boston,
Massachusetts
| $3.22B | +$305M | 10 | 6.64% | Increased |
|
| 22 |
Nuveen
Charlotte,
North Carolina
| $2.96B | +$226M | 65 | 1.44% | Increased |
|
| 23 |
Capital International Investors
Los Angeles,
California
| $2.93B | +$394M | 15 | 1.2% | Increased |
|
| 24 |
Goldman Sachs
New York
| $2.9B | -$357M | 81 | 1.02% | Reduced |
|
| 25 |
Franklin Resources
San Mateo,
California
| $2.89B | -$240M | 29 | 1.93% | Reduced |
|